{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T12:41:59Z","timestamp":1770986519463,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>hyaluronic acid (HA), a non-sulphated glycosaminoglycan, is present in synovial fluid, vitreous humour serum and many connective tissues. Pharmaceutical preparations of HA are used in clinical practice for wound healing, joint pain, kerato-conjunctivitis, asthma, mouth care, oesophageal-reflux, and gastritis. Moreover, it is used as a filler to counteract ageing and facial lipoatrophy. Our study aims at investigating the <jats:italic>in vitro<\/jats:italic> antiviral activity of a high molecular weight HA.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>the MTT test was used to rule out the potential toxic effects of HA on the different cell lines used in the antiviral assays. The antiviral activity of HA against Coxsackievirus B5, Herpes Simplex Virus-1, Mumps Virus, Adenovirus-5, Influenza Virus A\/H1N1, Human Herpesvirus-6, Porcine Parvovirus, Porcine Reproductive and Respiratory Syndrome Virus was assessed by virus yield assays.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>the most effective inhibition was observed against Coxsackievirus B5, with 3Log reduction of the virus yield at 4 mg\/ml, and a reduction of 3.5Log and 2Log, at 2 mg\/ml and 1 mg\/ml, respectively: the selectivity index was 16. Mumps virus was highly inhibited too showing a reduction of 1.7Log at 1 mg\/ml and 1Log at 4 mg\/ml and 2 mg\/ml (selectivity index = 12). The selectivity index for Influenza Virus was 12 with the highest inhibition (1Log) observed at 4 mg\/ml. Herpes Simplex Virus-1 and Porcine Parvovirus were mildly inhibited, whereas no antiviral activity was observed with respect to Adenovirus-5, Human Herpesvirus-6, Porcine Reproductive and Respiratory Syndrome Virus. No HA virucidal activity was ever observed against any of the viruses tested. Kinetic experiments showed that both Coxsackievirus B5 and Herpes simplex virus-1 replication were consistently inhibited, not influenced by the time of HA addition, during the virus replication cycle.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>the spectrum of the antiviral activity exhibited by HA against both RNA and DNA viruses, known to have different structures (with or without envelope) and replication strategies, suggests a non specific mechanism of action, probably involving cell membrane-virus interaction steps. The results of the kinetic experiments support this hypothesis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1743-422x-8-141","type":"journal-article","created":{"date-parts":[[2011,4,2]],"date-time":"2011-04-02T06:18:41Z","timestamp":1301725121000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["In vitro evaluation of antiviral and virucidal activity of a high molecular weight hyaluronic acid"],"prefix":"10.1186","volume":"8","author":[{"given":"Claudio","family":"Cermelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Cuoghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Scuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clotilde","family":"Bettua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachele G","family":"Neglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Ardizzoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Blasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommaso","family":"Iannitti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beniamino","family":"Palmieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,3,25]]},"reference":[{"issue":"7","key":"1252_CR1","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1096\/fasebj.6.7.1563592","volume":"6","author":"TC Laurent","year":"1992","unstructured":"Laurent TC, Fraser JR: Hyaluronan. FASEB J 1992,6(7):2397-2404.","journal-title":"FASEB J"},{"issue":"3","key":"1252_CR2","doi-asserted-by":"publisher","first-page":"536","DOI":"10.2165\/00003495-199447030-00009","volume":"47","author":"KL Goa","year":"1994","unstructured":"Goa KL, Benfield P: Hyaluronic acid. A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing. Drugs 1994,47(3):536-566. 10.2165\/00003495-199447030-00009","journal-title":"Drugs"},{"issue":"4","key":"1252_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/j.1473-2165.2006.00277.x","volume":"5","author":"DL Bissett","year":"2006","unstructured":"Bissett DL: Glucosamine: an ingredient with skin and other benefits. J Cosm Dermatol 2006,5(4):309-315. 10.1111\/j.1473-2165.2006.00277.x","journal-title":"J Cosm Dermatol"},{"issue":"1","key":"1252_CR4","first-page":"37","volume":"47","author":"GI Tiunnikov","year":"2002","unstructured":"Tiunnikov GI, Kostina GA, Radaeva IF, Bakulina LF: Effects of hyaluronic acid preparation on the development of herpetic infection in cell culture. Vopr Virusol 2002,47(1):37-39.","journal-title":"Vopr Virusol"},{"issue":"2","key":"1252_CR5","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1006\/viro.2000.0293","volume":"271","author":"LK Hallak","year":"2000","unstructured":"Hallak LK, Collins PL, Knudson W, Peeples ME: Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection. Virology 2000,271(2):264-275. 10.1006\/viro.2000.0293","journal-title":"Virology"},{"issue":"3","key":"1252_CR6","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1021\/bp990049c","volume":"15","author":"JM Le Doux","year":"1999","unstructured":"Le Doux JM, Morgan JR, Yarmush ML: Differential inhibition of retrovirus transduction by proteoglycans and free glycosaminoglycans. Biotechnol Prog 1999,15(3):397-406. 10.1021\/bp990049c","journal-title":"Biotechnol Prog"},{"issue":"3","key":"1252_CR7","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/sj.mt.6300044","volume":"15","author":"SR Chaudhuri","year":"2007","unstructured":"Chaudhuri SR, Mallam JN, Ch\u00e9vez-Barrios P, Wadhwa L, Ng P, Hurwitz MY, Hurwitz RL: Modulation of adenoviral transduction in vitro and in vivo by hyaluronan and its receptor CD44. Mol Ther 2007,15(3):566-70. 10.1038\/sj.mt.6300044","journal-title":"Mol Ther"},{"issue":"2","key":"1252_CR8","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0022-1759(86)90368-6","volume":"89","author":"F Denizot","year":"1986","unstructured":"Denizot F, Lang R: Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 1986,89(2):271-277. 10.1016\/0022-1759(86)90368-6","journal-title":"J Immunol Methods"},{"key":"1252_CR9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00284-007-9045-0","volume":"56","author":"C Cermelli","year":"2008","unstructured":"Cermelli C, Fabio A, Fabio G, Quaglio P: Effect of Eucalyptus Essential Oil on Respiratory Bacteria and Viruses. Curr Microbiol 2008, 56: 89-92. 10.1007\/s00284-007-9045-0","journal-title":"Curr Microbiol"},{"key":"1252_CR10","first-page":"45","volume-title":"Diagnostic procedures of Virus and Rickettsia Disease","author":"EH Lennette","year":"1964","unstructured":"Lennette EH: General principles underlying laboratory diagnosis of virus and rickettsia infections. In Diagnostic procedures of Virus and Rickettsia Disease. Edited by: Lennette EH, Schmidt NH. New York, American Public Health Association; 1964:45."},{"issue":"2","key":"1252_CR11","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.bbrc.2004.06.165","volume":"321","author":"GA Carlson","year":"2004","unstructured":"Carlson GA, Dragoo JL, Samimi B, Bruckner DA, Bernard GW, Hedrick M, Benhaim P: Bacteriostatic properties of biomatrices against common orthopaedic pathogens. Biochem Biophys Res Commun 2004,321(2):472-478. 10.1016\/j.bbrc.2004.06.165","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"1252_CR12","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1902\/jop.1999.70.4.370","volume":"70","author":"P Pirnazar","year":"1999","unstructured":"Pirnazar P, Wolinsky L, Nachnani S, Haake S, Pilloni A, Bernard GW: Bacteriostatic effects of hyaluronic acid. J Periodontol 1999,70(4):370-374. 10.1902\/jop.1999.70.4.370","journal-title":"J Periodontol"},{"issue":"11","key":"1252_CR13","doi-asserted-by":"publisher","first-page":"3856","DOI":"10.1128\/AAC.00082-06","volume":"50","author":"KJ Zaleski","year":"2006","unstructured":"Zaleski KJ, Kolodka T, Cywes-Bentley C, McLoughlin RM, Delaney ML, Charlton BT, Johnson W, Tsianabos AO: Hyaluronic acid binding peptides prevent experimental staphylococcal wound infection. Antimicrob Agents Chemother 2006,50(11):3856-60. 10.1128\/AAC.00082-06","journal-title":"Antimicrob Agents Chemother"},{"issue":"13","key":"1252_CR14","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1021\/jm000412i","volume":"44","author":"RM Marks","year":"2001","unstructured":"Marks RM, Lu H, Sundaresan R, Toida T, Suzuki A, Imanari T, Hern\u00e0iz MJ, Lindhardt RJ: Probing the interaction of dengue virus envelope protein with heparin: assessment of glycosaminoglycan-derived inhibitors. J Med Chem 2001,44(13):2178-87. 10.1021\/jm000412i","journal-title":"J Med Chem"},{"issue":"43","key":"1252_CR15","doi-asserted-by":"publisher","first-page":"29654","DOI":"10.1074\/jbc.M109.037960","volume":"284","author":"CD O'Donnell","year":"2009","unstructured":"O'Donnell CD, Shukla D: A novel function of heparan sulfate in the regulation of cell-cell fusion. J Biol Chem 2009,284(43):29654-29665.","journal-title":"J Biol Chem"},{"issue":"23","key":"1252_CR16","doi-asserted-by":"publisher","first-page":"4468","DOI":"10.1016\/j.febslet.2007.08.029","volume":"581","author":"V Tiwari","year":"2007","unstructured":"Tiwari V, ten Dam GB, Yue BY, van Kuppevelt TH, Shukla D: Role of 3-O-sulfated heparan sulfate in virus-induced polykaryocyte formation. FEBS Lett 2007,581(23):4468-4472. 10.1016\/j.febslet.2007.08.029","journal-title":"FEBS Lett"},{"key":"1252_CR17","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1128\/jvi.63.1.52-58.1989","volume":"63","author":"D WuDunn","year":"1989","unstructured":"WuDunn D, Spear PG: Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J Virol 1989, 63: 52-58.","journal-title":"J Virol"},{"issue":"Pt 3","key":"1252_CR18","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1099\/vir.0.19603-0","volume":"85","author":"E Escribano-Romero","year":"2004","unstructured":"Escribano-Romero E, Jimenez-Clavero MA, Gomes P, Garcia-Ranea JR, Ley V: Heparan sulphate mediates swine vesicular disease virus attachment to the host cell. J Gen Virol 2004,85(Pt 3):653-663. 10.1099\/vir.0.19603-0","journal-title":"J Gen Virol"},{"issue":"18","key":"1252_CR19","doi-asserted-by":"publisher","first-page":"10071","DOI":"10.1128\/JVI.77.18.10071-10077.2003","volume":"77","author":"AE Zautner","year":"2006","unstructured":"Zautner AE, K\u00f6rner U, Henke A, Badorff C, Schmidtke M: N- and 6-O-sulfated heparan sulfates mediate internalization of coxsackievirus B3 variant PD into CHO-K1 cells. J Virol 2006,77(18):10071-10077. 10.1128\/JVI.77.18.10071-10077.2003","journal-title":"J Virol"},{"issue":"13","key":"1252_CR20","doi-asserted-by":"publisher","first-page":"6629","DOI":"10.1128\/JVI.01988-05","volume":"80","author":"AE Zautner","year":"2003","unstructured":"Zautner AE, Jahn B, Hammerschmidt E, Wutzler P, Schmidtke M: Heparan sulfates and coxsackievirus-adenovirus receptor: each one mediates coxsackievirus B3 PD infection. J Virol 2003,80(13):6629-6636. 10.1128\/JVI.01988-05","journal-title":"J Virol"},{"key":"1252_CR21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1084\/jem.20001858","volume":"195","author":"C Termeer","year":"2002","unstructured":"Termeer C, Benedix F, Sleeman J, Fieber C, Voith U, Ahrens T, Miyake K, Freudenberg M, Galanos C, Simon JC: Oligosaccharides of hyaluronan activate dendritic cells via Toll-like receptor 4. J Exp Med 2002, 195: 99-111. 10.1084\/jem.20001858","journal-title":"J Exp Med"},{"key":"1252_CR22","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cellimm.2010.02.013","volume":"262","author":"MA Wallet","year":"2010","unstructured":"Wallet MA, Wallet SM, Guiulfo G, Sleasman JW, Goodenow MM: IFN\u03b3 primes macrophages for inflammatory activation by high molecular weight hyaluronan. Cell Immunol 2010, 262: 84-88. 10.1016\/j.cellimm.2010.02.013","journal-title":"Cell Immunol"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-8-141.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T13:43:08Z","timestamp":1630503788000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/1743-422X-8-141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,25]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1252"],"URL":"https:\/\/doi.org\/10.1186\/1743-422x-8-141","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,25]]},"assertion":[{"value":"24 September 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"141"}}